Prodia Diagnostic Line is trading IDR 212, 3.6% down, continuing a seven-session decline from IDR 254 on September 8, 2026.
- No credible company-specific announcement dated September 17, 2026 was identified.
- Available coverage discusses earlier IPO developments, expansion plans, and a first-half loss, but does not explicitly link them to the decline.
- Broader market evidence is mixed, leaving the catalyst unclear.